Follow The Filings

DOCS Doximity Inc.

Health Care, filed as DOXIMITY INC (CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $14M
  • 1 reduce

In 2026 Q2 Terry Smith trimmed Doximity.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Terry Smith, Fundsmith). Not free-float ownership.

  1. Terry Smith Reduce 0.10%

Who owns DOCS

Sorted by value, long equity only, as of 2026 Q2.

History
Terry Smith, Fundsmith 0.10%, was 0.13% Reduce −5.6% 653,324 $14M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DOCS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DOCS insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $1.7M sold by 3 insiders under 10b5-1 plans
  1. Kira Scherer Wampler Director
    Planned sale
    $58K 2,000 shares at $28.91 6.7% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  2. Watkin Phoebe L. Yang Director
    Planned sale
    $34K 1,290 shares at $26.71 5% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  3. Kira Scherer Wampler Director
    Planned sale
    $53K 2,000 shares at $26.33 6.7% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  4. Kira Scherer Wampler Director
    Planned sale
    $50K 2,000 shares at $24.95 9.2% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  5. Timothy S Cabral Director
    Planned sale
    $293K 7,500 shares at $39.11 70% of stake
    Traded Aug 7 Filed Aug 11
    ↗
  6. Kira Scherer Wampler Director
    Planned sale
    $235K 9,000 shares at $26.06 31% of stake
    Traded May 7 Filed May 8
    ↗
  7. Kira Scherer Wampler Director
    Planned sale
    $52K 2,000 shares at $26.00 9.2% of stake
    Traded Mar 3 Filed Mar 5
    ↗
  8. Kira Scherer Wampler Director
    Planned sale
    $75K 2,000 shares at $37.33 9.2% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  9. Kira Scherer Wampler Director
    Planned sale
    $89K 2,000 shares at $44.65 9.2% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  10. Kira Scherer Wampler Director
    Planned sale
    $101K 2,000 shares at $50.71 9.2% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  11. Timothy S Cabral Director
    Planned sale
    $500K 10,000 shares at $50.00 76% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
  12. Kira Scherer Wampler Director
    Planned sale
    $133K 2,000 shares at $66.44 9.2% of stake
    Traded Nov 3, 2025 Filed Nov 5, 2025
    ↗
  13. Regina M. Benjamin Director
    Planned sale
    $354K 5,000 shares at $70.84 20% of stake
    Traded Oct 10, 2025 Filed Oct 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 conversions, 14 stock grants, 11 share withholdings for taxes, and 9 sales to cover taxes.

Congress

1 member of Congress traded DOCS in the last three years: 1 buy and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Jonathan L. Jackson D-IL-1Joint Sell $15K–$50K Nov 6, 2025 filed Dec 5, 2025
  2. Jonathan L. Jackson D-IL-1Joint Buy $15K–$50K Aug 25, 2025 filed Sep 23, 2025

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $419.05M $475.42M $570.4M $644.86M
Gross profit $365.56M $424.75M $514.52M $574.54M
Gross margin * 87.2% 89.3% 90.2% 89.1%
Net income $112.82M $147.58M $223.18M $196.05M
Net margin * 26.9% 31.0% 39.1% 30.4%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $0.975B $0.913B $1.09B $0.944B
Total non-current assets * $161.44M $166.43M $175.69M $179.42M
Total assets $1.14B $1.08B $1.26B $1.12B
Total current liabilities $139.51M $147.25M $156.26M $154.97M
Total non-current liabilities * $31.26M $30.73M $25.43M $17.88M
Total equity $0.966B $0.901B $1.08B $0.951B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $179.6M $184.1M $273.26M $326.46M
Cash from investing -$59.92M $31.19M -$29.3M $147.17M
Cash from financing -$74.46M -$276.52M -$131.14M -$464.06M
Net change in cash $45.22M -$61.24M $112.83M $9.56M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.